20% Alcohol With Steroid Local Anesthetic Technique Versus Steroid Local Anesthetic Technique Only in Stellate Ganglion Injection in Idiopathic Palmar Hyperhydrosis

NCT07788326 | Not Yet Recruiting DMC

• 1 other identifier: D 498
• Study Type: interventional
• Target: 50
• Locations: 0 countries
• Sites: N/A

Brief Summary

Palmar hyperhidrosis is a medical condition characterized by excessive sweating specifically from the palms of the hands. This condition can significantly impact an individual's quality of life, leading to social embarrassment, anxiety, and difficulties in daily activities. It is classified as a type of primary hyperhidrosis, which means it occurs without an identifiable underlying medical cause. The prevalence of palmar hyperhidrosis is estimated to affect about 1% to 3% of the population. Symptoms typically begin in childhood or adolescence, often becoming more pronounced during periods of hormonal changes such as puberty. The condition may run in families, suggesting a genetic predisposition. The underlying mechanism involves hyperactivity of the sympathetic nervous system, particularly affecting the eccrine sweat glands located in the palms . Unlike normal sweating, which primarily serves thermoregulation (cooling the body), palmar hyperhidrosis is triggered by emotional stimuli such as stress or anxiety rather than heat. This inappropriate activation leads to excessive sweating that can occur even at rest . Diagnosis is primarily clinical and based on patient history and visible signs of excessive sweating. Patients often report episodes that are bilateral and symmetrical, with cold and wet palms that may appear pale or blushed. The diagnosis does not typically require extensive testing unless secondary causes are suspected. Treatment for palmar hyperhidrosis can be challenging due to varying degrees of severity and individual responses to therapies. Common treatment options include topical treatments as aluminum chloride hexahydrate which is considered one of the most effective topical treatments for palmar hyperhidrosis. It works by blocking sweat pores and reducing gland activity. Application involves using a concentrated solution on dry skin at night until symptoms improve, followed by maintenance therapy. Another option of treatment is iontophoresis; this technique uses electrical currents to temporarily block sweat gland function. It requires multiple sessions but can be effective for many patients. Botulinum toxin type A can be injected into affected areas to inhibit neurotransmitter release responsible for activating sweat glands. While effective, this treatment requires repeated injections every few months due to its temporary effects . Anticholinergic drugs have been used but are often limited by side effects such as dry mouth and constipation at effective dosages . Regarding surgical options; surgical sympathectomy is considered a last resort for severe cases where other treatments have failed. This procedure involves cutting nerves that trigger sweating but carries risks such as compensatory sweating in other body areas. Finally, palmar hyperhidrosis is a common yet often underreported condition that can severely affect individuals' lives due to its social implications and discomfort associated with excessive sweating. Treatment options vary widely in effectiveness and side effects, necessitating a tailored approach based on individual needs.

Conditions

Hyperhidrosis

Keywords

idiopathic palmoplantar hyperhidrosis; stellate ganglion injection

Outcome Measures

Primary Outcomes (1)

• hyperhydrosis severity scale

  presence/absence of hyperhidrosis

  After 1 hour of injection

Study Arms (2)

Stellate Ganglion Block 20% alcohol with steroid local anesthetic technique

ACTIVE COMPARATOR

Procedure: Group A

Stellate Ganglion Block steroid local anesthetic technique only

ACTIVE COMPARATOR

Procedure: Group B

Interventions

Group A PROCEDURE

The aim of the study is to compare between 20% alcohol with steroid local anesthetic technique versus steroid local anesthetic technique only in stellate ganglion injection in treatment of idiopathic palmoplantar hyperhidrosis.

Stellate Ganglion Block 20% alcohol with steroid local anesthetic technique

Group B PROCEDURE

The aim of the study is to compare between 20% alcohol with steroid local anesthetic technique versus steroid local anesthetic technique only in stellate ganglion injection in treatment of idiopathic palmoplantar hyperhidrosis.

Stellate Ganglion Block steroid local anesthetic technique only

Eligibility Criteria

• Age: 18 Years - 45 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Age from 18 to 45 years.
• Both genders.
• Exhibiting primary palmar hyperhidrosis.
• All patients with hyperhidrosis and were socially, professionally, and psychologically handicapped.
• All patients with failed previous dermatological topical treatment as aluminum chloride hexahydrate

You may not qualify if:

• An inability of patient to cooperate.
• Known allergies to alcohol or local anaesthetic.

Sponsors & Collaborators

• Fayoum University Hospital: lead

Related Publications (16)

• Ambrogi V, Campione E, Mineo D, Paterno EJ, Pompeo E, Mineo TC. Bilateral thoracoscopic T2 to T3 sympathectomy versus botulinum injection in palmar hyperhidrosis. Ann Thorac Surg. 2009 Jul;88(1):238-45. doi: 10.1016/j.athoracsur.2009.04.003.

  PMID: 19559233 BACKGROUND

• Choi HG, Kwon SY, Won JY, Yoo SW, Lee MG, Kim SW, Park B. Comparisons of Three Indicators for Frey's Syndrome: Subjective Symptoms, Minor's Starch Iodine Test, and Infrared Thermography. Clin Exp Otorhinolaryngol. 2013 Dec;6(4):249-53. doi: 10.3342/ceo.2013.6.4.249. Epub 2013 Nov 29.

  PMID: 24353866 BACKGROUND

• Chudry H. The treatment of palmar hyperhidrosis - a systematic review. Int J Dermatol. 2022 Nov;61(11):1303-1310. doi: 10.1111/ijd.15937. Epub 2021 Oct 15.

  PMID: 34653261 BACKGROUND

• Henning MAS, Thorlacius L, Ibler KS, Jemec GBE. How to diagnose and measure primary hyperhidrosis: a systematic review of the literature. Clin Auton Res. 2021 Aug;31(4):511-528. doi: 10.1007/s10286-021-00794-6. Epub 2021 Mar 27.

  PMID: 33772671 BACKGROUND

• Kisielnicka A, Szczerkowska-Dobosz A, Purzycka-Bohdan D, Nowicki RJ. Hyperhidrosis: disease aetiology, classification and management in the light of modern treatment modalities. Postepy Dermatol Alergol. 2022 Apr;39(2):251-257. doi: 10.5114/ada.2022.115887. Epub 2022 May 9.

  PMID: 35645673 BACKGROUND

• Kuijpers M, van Zanden JE, Harms PW, Mungroop HE, Mariani MA, Klinkenberg TJ, Bouma W. Minimally Invasive Sympathicotomy for Palmar Hyperhidrosis and Facial Blushing: Current Status and the Hyperhidrosis Expert Center Approach. J Clin Med. 2022 Jan 31;11(3):786. doi: 10.3390/jcm11030786.

  PMID: 35160238 BACKGROUND

• Martina E, Diotallevi F, Radi G, Campanati A, Offidani A. Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review. Toxins (Basel). 2021 Feb 5;13(2):120. doi: 10.3390/toxins13020120.

  PMID: 33562846 BACKGROUND

• Nastase F, Busila C, Nicolescu AC, Marin CM, Tatu AL. Iontophoresis Improves the Impact on the Quality of Life of Children with Primary Hyperhidrosis-A Prospective Study and a Short Review. Children (Basel). 2024 Oct 17;11(10):1253. doi: 10.3390/children11101253.

  PMID: 39457218 BACKGROUND

• Purtuloglu T, Atim A, Deniz S, Kavakli K, Sapmaz E, Gurkok S, Kurt E, Turan A. Effect of radiofrequency ablation and comparison with surgical sympathectomy in palmar hyperhidrosis. Eur J Cardiothorac Surg. 2013 Jun;43(6):e151-4. doi: 10.1093/ejcts/ezt024. Epub 2013 Feb 21.

  PMID: 23428574 BACKGROUND

• Rahim M, Ahmed N, Naz Khan K, Memon S, Naveed T, Shah SA, Farooq O, Ali U. Comparison of the Efficacy of Tap Water Iontophoresis Versus Aluminum Chloride Hexahydrate in the Treatment of Palmoplantar Hyperhidrosis. Cureus. 2022 Dec 9;14(12):e32367. doi: 10.7759/cureus.32367. eCollection 2022 Dec.

  PMID: 36627989 BACKGROUND

• Schote AB, Dietrich K, Linden AE, Dzionsko I, Molano Moreno LLA, Winnikes U, Zimmer P, Domes G, Meyer J. Real sweating in a virtual stress environment: Investigation of the stress reactivity in people with primary focal hyperhidrosis. PLoS One. 2022 Aug 2;17(8):e0272247. doi: 10.1371/journal.pone.0272247. eCollection 2022.

  PMID: 35917298 BACKGROUND

• Solish MJ, Savinova I, Weinberg MJ. A Practical Approach to the Diagnosis and Treatment of Palmar Hyperhidrosis. Plast Reconstr Surg Glob Open. 2022 Mar 7;10(3):e4172. doi: 10.1097/GOX.0000000000004172. eCollection 2022 Mar.

  PMID: 35265447 BACKGROUND

• Solish N, Bertucci V, Dansereau A, Hong HC, Lynde C, Lupin M, Smith KC, Storwick G; Canadian Hyperhidrosis Advisory Committee. A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee. Dermatol Surg. 2007 Aug;33(8):908-23. doi: 10.1111/j.1524-4725.2007.33192.x.

  PMID: 17661933 BACKGROUND

• Trettin B, Hansen J, Bygum A. The impact of adolescents' everyday life experiences on their primary hyperhidrosis treatment - a qualitative study. J Dermatolog Treat. 2022 Mar;33(2):928-934. doi: 10.1080/09546634.2020.1789541. Epub 2020 Jul 22.

  PMID: 32628056 BACKGROUND

• Wadhawa S, Agrawal S, Chaudhary M, Sharma S. Hyperhidrosis Prevalence: A Disease Underreported by Patients and Underdiagnosed by Physicians. Indian Dermatol Online J. 2019 Nov 1;10(6):676-681. doi: 10.4103/idoj.IDOJ_55_19. eCollection 2019 Nov-Dec.

  PMID: 31807447 BACKGROUND

• Wong NS, Adlam TM, Potts GA, Farshchian M. Hyperhidrosis: A Review of Recent Advances in Treatment with Topical Anticholinergics. Dermatol Ther (Heidelb). 2022 Dec;12(12):2705-2714. doi: 10.1007/s13555-022-00838-3. Epub 2022 Nov 3.

  PMID: 36329359 BACKGROUND

MeSH Terms

Conditions

Hyperhidrosis

Condition Hierarchy (Ancestors)

Sweat Gland Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Study Officials

• Atef M Sayed, MD

  Faculty of medicine, Fayoum university

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Ahmed S Abdalla, M.Sc

CONTACT

1069291684; asa43@fayoum.edu.eg

Atef M Sayed, MD

CONTACT

10 03973883; amk04@fayoum.edu.eg

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: QUADRUPLE
• Who Masked: PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associated Professor

Study Record Dates

• First Submitted: August 22, 2026
• First Posted: August 26, 2026
• Study Start (Estimated): September 1, 2026
• Primary Completion (Estimated): October 1, 2027
• Study Completion (Estimated): October 1, 2027
• Last Updated: August 26, 2026

Record last verified: 2026-08

Data Sharing

• IPD Sharing: Will not share